Harald Hoffmann

Pharmaceutics, Emerging Microbes and Infections
3
Role Title Level Year L/R
🐜 A Single-Run HPLC–MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis
21 auth. N. Köhler, Hande Karaköse, H. Grobbel, D. Hillemann, S. Andres, Christina König, Barbara Kalsdorf, T. Brehm, L. Böttcher, I. Friesen, ... Harald Hoffmann, Dražen Strelec, Dagmar Schaub, C. Peloquin, S. Schmiedel, L. A. Decosterd, E. Choong, S. Wicha, R. Aarnoutse, Christoph Lange, P. S. Sánchez Carballo 		2 2023 2
🐜
🐢 Development of prevalence and incidence of non-tuberculous mycobacteria in German laboratories from 2016 to 2020
24 auth. C. Corbett, Philipp Finger, M. Heiß-Neumann, Juergen Bohnert, Ines B Eder, Melanie Eisele, Inna Friesen, Achim J. Kaasch, J. Kehrmann, Roland Lang, ... Juergen Roedel, Susann Roessler, Annika Schmidt, Sophie Schneitler, Daniela Schui, Franziska Schuler, Ludwig Sedlacek, Annerose Serr, A. Sitaru, Joerg Steinmann, Dirk Wagner, T. Wichelhaus, S. Hofmann-Thiel, Harald Hoffmann 		2 2023 2
🐢